Back

MDA Case Discussions: Navigating Diagnosis and Treatment Decisions in Myasthenia Gravis

This 1-hour interactive program will guide clinicians through real-world MG cases designed to strengthen diagnostic reasoning and treatment planning across diverse presentations. Led by a neurologist chair, the session will emphasize how to apply clinical clues and testing strategies to differentiate MG from alternative neuromuscular, neurologic, and systemic disorders. Participants will work through cases illustrating challenges such as early-stage or ocular-predominant disease, late-onset MG, seronegative presentations, crisis risk assessment, and response variability to immunotherapies. Discussion will incorporate interpretation of antibody panels, repetitive nerve stimulation and single-fiber EMG results, pulmonary function testing, and assessment of treatment efficacy. Management content will address both acute and long-term strategies, including optimizing steroid-sparing regimens, integrating targeted biologics, and monitoring for adverse effects or disease exacerbation triggers.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1 creditAAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 creditSocial WorkUp to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

No specific specialties targeted.

  • Enduring / On-demand
  • Credit · Up to 1 credit
  • Paid · fee on provider site
  • Commercial Support
  • Released
    Sep 29, 2026
  • Last day to claim credit
    Oct 7, 2028 2 years left